| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 41.6246 | 12 |
| GSM780708 | Untreated after 4 days (C2_1) | 45.5493 | 30 |
| GSM780709 | Untreated after 4 days (C3_1) | 41.5135 | 11 |
| GSM780719 | Untreated after 4 days (C1_2) | 46.9891 | 37 |
| GSM780720 | Untreated after 4 days (C2_2) | 43.6901 | 21 |
| GSM780721 | Untreated after 4 days (C3_2) | 40.2864 | 7 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 42.1126 | 14 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 47.7056 | 40 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 47.5604 | 39 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 37.897 | 2 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 51.9645 | 54 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 43.0918 | 18 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 58.055 | 63 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 42.6023 | 16 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 77.2399 | 71 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 56.5991 | 61 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 42.4664 | 15 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 65.743 | 67 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 37.568 | 2 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 48.0827 | 41 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 36.7014 | 1 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 46.5894 | 35 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 51.9811 | 54 |